跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Grunenthal Pharma Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 1, 2023
Approval ID
483be66743f30245
Company
Grunenthal Pharma Limited
Type
Standard
Approval Details
Approval Id
483be66743f30245
Drug Cima Aemps Name
ZALDIAR 37,5 MG/325 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
PA2242006001
Holder Company Name
Grunenthal Pharma Limited
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-12-01
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
37,5 mg tramadol hidrocloruro/325 mg paracetamol
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Grunenthal Pharma Limited
Active Ingredients
PARACETAMOL
325 IP
TRAMADOL HIDROCLORURO
37,5 IP
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 1, 2023
Approval ID
483be66743f30245
Type
Standard
Back to CIMA-AEMPS Approvals